benphothiamine has been researched along with Hearing Loss, Sensorineural in 5 studies
benfotiamine : A thioester that is a synthetic analogue of thiamine obtained by acylative cleavage of the thiazole ring and O-phospohorylation.
Hearing Loss, Sensorineural: Hearing loss resulting from damage to the COCHLEA and the sensorineural elements which lie internally beyond the oval and round windows. These elements include the AUDITORY NERVE and its connections in the BRAINSTEM.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dalwadi, P | 1 |
Joshi, AS | 1 |
Thakur, DS | 1 |
Bhagwat, NM | 1 |
Kornienko, AM | 1 |
Kornienko, RA | 1 |
Antoniv, VF | 1 |
Efimochkina, KV | 1 |
Antoniv, TV | 1 |
Popadiuk, VI | 1 |
Kakupshev, AU | 1 |
Atanesian, AG | 1 |
Kosiakov, SIa | 1 |
Manuĭlov, OE | 1 |
Bezzubenko, LA | 1 |
1 trial available for benphothiamine and Hearing Loss, Sensorineural
Article | Year |
---|---|
[Milgamma in the treatment of chronic neurosensory hypoacusis].
Topics: Adjuvants, Immunologic; Adult; Aged; Chronic Disease; Hearing Loss, Sensorineural; Humans; Middle Ag | 2004 |
4 other studies available for benphothiamine and Hearing Loss, Sensorineural
Article | Year |
---|---|
Neonatal diabetes mellitus: remission induced by novel therapy.
Topics: Administration, Oral; Anemia, Megaloblastic; Diabetes Mellitus; Diabetic Ketoacidosis; Female; Frame | 2019 |
[Sensorineural hearing loss: New prospects for therapy].
Topics: Adjuvants, Immunologic; Administration, Oral; Aged; Audiometry; Disease Progression; Dose-Response R | 2011 |
[The importance of the pharmaceutical form and the routes of administration of B-group vitamins for the efficacious treatment of neurosensorial hearing loss].
Topics: Adult; Biopharmaceutics; Cochlear Nerve; Hearing Loss, Sensorineural; Humans; Male; Nerve Regenerati | 2012 |
[The role of neurotropic therapy in the treatment of acute sensorineural impairment of hearing following a viral infection].
Topics: Acute Disease; Adjuvants, Immunologic; Adult; Biological Availability; Cochlear Nerve; Drug Monitori | 2012 |